e-learning
resources
Barcelona 2013
Saturday, 07.09.2013
PG3 Infections and critical patients: emerging problems and clinical strategies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Extracorporeal therapies in sepsis: from toraymyxin to CPFA
M. Antonelli (Rome, Italy)
Source:
Annual Congress 2013 –PG3 Infections and critical patients: emerging problems and clinical strategies
Session:
PG3 Infections and critical patients: emerging problems and clinical strategies
Session type:
Postgraduate Course
Number:
23
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Antonelli (Rome, Italy). Extracorporeal therapies in sepsis: from toraymyxin to CPFA. Annual Congress 2013 –PG3 Infections and critical patients: emerging problems and clinical strategies
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Extracorporeal devices
Source: Annual Congress 2013 –Ceremony for ERS Research Award on Idiopathic Pulmonary Fibrosis (financially supported by InterMune) followed by Clinical Year in Review I
Year: 2013
The EOLIA trial and ECMO in veno-venous extracorporeal membrane oxygenation therapy: where we are now and where to go
Source: International Congress 2019 – Extracorporeal membrane oxygenation now and in the future
Year: 2019
Extracorporeal photopheresis: an effective treatment for pulmonary graft versus host disease
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020
Advanced therapies for life-threatening PE: low-dose systemic thrombolysis, catheter-directed thrombolysis and extracorporeal membrane oxygenation (ECMO)
Source: International Congress 2018 – Pulmonary embolism: what we need to know
Year: 2018
Extracorporeal ventilatory support
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=220
Year: 2002
Early physiotherapy in the clinical course of patients on Veno-Venous Extracorporeal Membrane Oxygenation.
Source: International Congress 2018 – Acutely hospitalised patients: physiotherapy interventions and assessment methods
Year: 2018
Extracorporeal membrane oxygenation as rescue therapy for severe ARDS due to autoimmune diffuse alveolar haemorrhage
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019
Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012
Case presentation: Extracorporeal CO2 removal and veno venous ECMO as bridge to transplantation in refractory hypercapnic respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Extracorporeal photopheresis after lung transplantation: a 10-year single-centre experience
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008
Extracorporeal membrane oxygenation for the treatment of acute exacerbation of interstitial lung diseases
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): treatment highlights
Year: 2017
Extracorporeal membrane oxygenation as bridge in patients with non-iatrogenic massive hemoptysis
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012
Extracorporeal membrane oxygenation
Source: Eur Respir Mon 2012; 55: 133-141
Year: 2012
Extracorporeal membrane oxygenation (ECMO) for near fatal asthma refractory to conventional ventilation
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016
Lung transplant bridge with extracorporeal devices (ECMO and Novalung)
Source: School Course 2012 - Lung Transplantation
Year: 2012
Extracorporeal life support (ECLS) as a bridge to lung transplantation (LTx)
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012
Extracorporeal assistance as bridge and as support during transplantation
Source: International Congress 2019 – Therapeutic breakthrough Year in review
Year: 2019
Job‘s syndrome post extracorporeal membrane oxygenation (ECMO)
Source: Eur Respir J 2006; 28: Suppl. 50, 487s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept